DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Transcatheter mitral valve replacement (TMVR) Market - Global Industry Analysis, Size, Share, Trends and Forecast, 2014-2022" report to their offering.
The market for TMVR is expected to reach around USD 3.0 billion by 2022, growing at a CAGR of 15.9% during the forecast period of 2016e to 2022f.
However, there are certain restraining factors which could hamper the growth of this market, which includes, high costs associated with the LMVD implantation compared to other therapies available for CVD diseases.
The mitral valve, also known as the bicuspid valve or left atrio-ventricular valve, is a dual-flap valve in the heart that lies between the left atrium and the left ventricle. The mitral valve and the tricuspid valve are known collectively as the atrio-ventricular valves because they lie between the atria and the ventricles of the heart.
The mitral valve manages blood flow between left atrium and left ventricle; and prevents backward flow of the blood into left atrium. Mitral regurgitation is leakage of blood backward through the mitral valve each time the left ventricle contracts. This is a most common mitral valve disorder that causes abnormal blood flow. As a remedy for this problem, surgeons use mitral surgical vale repair procedures or transcatheter replacement methods.
Some of the key driving factors attributing to the growth of this market include increasing number of patients with mitral valve disorders. Approximately 7 million people in the U.S., suffer from mitral regurgitation in the U.S., and they represent almost 2% of the nation's population. Similarly, approximately the same number of people suffer from the condition in Europe. This group includes 4.1 million people who have moderate to severe mitral regurgitation.
Key Topics Covered:
1 Scope of the report
2 Executive summary
3 Qualitative analysis
3.1 Market overview
3.2 Value chain analysis
3.3 Porters five forces analysis
3.4 Key M&A trends and strategic partnerships
3.5 Competitive matrix of the key companies
4 Global TMVR market, by geography, 2014-2022f
5 Company profiles
5.1 Edwards Lifesciences Corp.
5.2 Medtronic plc
5.3 Abbott Laboratories
5.4 Micro Interventional Devices
For more information about this report visit http://www.researchandmarkets.com/research/qkhjfs/transcatheter